GLP1R and Parkinson disease: A recent study in a transgenic mouse model of PD suggests that enhancing GLP‐1 secretion in the enteric nervous system offers central and enteric neuroprotection against synucleinopathy‐induced neurodegeneration (Pradeloux et al. 2024).